Bezielle Selectively Targets Mitochondria of Cancer Cells to Inhibit Glycolysis and OXPHOS

Open Access

Peer-reviewed

Research Article

Vivian Chen,

Affiliation BioNovo, Inc., Emeryville, California, United States of America
⨯
Richard E. Staub,

Affiliation BioNovo, Inc., Emeryville, California, United States of America
⨯
Sylvia Fong,

Affiliation BioNovo, Inc., Emeryville, California, United States of America
⨯
Mary Tagliaferri,

Affiliation BioNovo, Inc., Emeryville, California, United States of America
⨯
Isaac Cohen,

Affiliation BioNovo, Inc., Emeryville, California, United States of America
⨯
Emma Shtivelman

* E-mail: emmas@bionovo.com

Affiliation BioNovo, Inc., Emeryville, California, United States of America
⨯

Reader Comments (0)

Mitochondria
Is the Subject Area "Mitochondria" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
DNA damage
Is the Subject Area "DNA damage" applicable to this article?

Thanks for your feedback.
Cell death
Is the Subject Area "Cell death" applicable to this article?

Thanks for your feedback.
Glycolysis
Is the Subject Area "Glycolysis" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Superoxides
Is the Subject Area "Superoxides" applicable to this article?

Thanks for your feedback.
Cell metabolism
Is the Subject Area "Cell metabolism" applicable to this article?

Thanks for your feedback.